EXPRES2ION BIOTECHNOLOGIES

ExpreS2ion Biotechnologies is a world leading biotech company.

#SimilarOrganizations #People #More

EXPRES2ION BIOTECHNOLOGIES

Industry:
Biotechnology Health Care Pharmaceutical

Status:
Active


Similar Organizations

not_available_image

Guardian Biotechnologies

Guardian Biotechnologies is a biotechnology company.

protein-technologies-logo

Protein Technologies

Protein Technologies Ltd. (PTL) is an award-winning, biotech company.


Current Advisors List

gitte-pedersen_image

Gitte Pedersen Board Member @ ExpreS2ion Biotechnologies
Board_member
2016-01-01

More informations about "ExpreS2ion Biotechnologies"

Company - ExpreS2ion Biotechnologies

Board Member at ExpreS2ion Biotechnologies ApS, Ingeniørsystem A/S, and PV Fonden. Mr. Knudsen has been an independent member of the board since 2017. Shares: 4,990 TO 11 โ€ฆSee details»

ExpreS2ion Biotechnologies - Wikipedia

ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the โ€ฆSee details»

ExpreS2ion - Crunchbase Company Profile & Funding

ExpreS2ion is a biotechnology company that develops innovative vaccines for a healthier world. We want to transform healthcare by developing novel vaccines, that are life-saving and โ€ฆSee details»

ExpreS2ion Biotechnologies - LinkedIn

ExpreS2ion Biotechnologies ApS is a fully owned Danish subsidiary and operational unit of ExpreS2ion Biotech Holding AB, listed on Nasdaq First North Growth Market, Stockholm (Ticker: EXPRS2). WebsiteSee details»

Proprietary Pipeline - ExpreS2ion Biotechnologies

ExpreS2ion Biotechnologies ApS: CVR/VAT: DK32770487 Agern Allé 1 DK-2970 Hørsholm, Denmark Contact: [email protected] +45 22 22 10 19. Holding Company ExpreS2ion โ€ฆSee details»

ExpreS2ion Biotechnologies - innovative vaccines for a healthier โ€ฆ

EXPRES2ION 2024 FIRST QUARTER INTERIM REPORT Company structure ExpreS2ion Biotech Holding AB is a limited company which has been listed on the Nasdaq First North โ€ฆSee details»

Proteins for life - ExpreS2ion Biotechnologies

ExpreS2ion Biotechnologies ApS was founded in 2010 on the realisation that to produce the complex proteins needed for biological drugs and vaccines of the future, in a safer and more โ€ฆSee details»

ExpreS2ion - Org Chart, Teams, Culture & Jobs - The Org

View ExpreS2ion's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. Explore. Vision. Log in. Sign up. ExpreS2ion. โ€ฆSee details»

ExpreS2ion Biotechnologies - 2025 Company Profile - Tracxn

Apr 11, 2025 ExpreS2ion Biotechnologies has raised funding over 4 rounds. Its first funding round was on Jan 01, 2017. Its latest funding round was a Grant (prize money) round on Apr โ€ฆSee details»

ExpreS2ion Biotech Holding AB Company Description - Stock โ€ฆ

Mar 17, 2025 ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2ion Biotechnologies ApS, researches and develops preventive and therapeutic vaccine products in โ€ฆSee details»

Expres2ion Biotechnologies - VentureRadar

ExpreS2ion Biotechnologies is a world leading CRO biotech company within protein production in Drosophila Schneider-2 (S2) cells. Our company has a proprietary and complete S2 โ€ฆSee details»

ExpreS2ion Biotechnologies - innovative vaccines for a healthier โ€ฆ

EXPRES2ION 2023 YEAR-END REPORT Company structure ExpreS2ion Biotech Holding AB is a limited company which has been listed on the Nasdaq First North Growth Market in Sweden โ€ฆSee details»

ExpreS2ion Biotechnologies | DANISH BIO โ€“ DANSK BIOTEK

ExpreS2ion Biotechnologies ExpreS 2 ion combines a unique production platform, ExpreS 2 , for fast and efficient development of new therapeutics and diagnostics, and a universal capsid โ€ฆSee details»

ExpreS2ion Biotechnologies: Revenue, Worth, Valuation

About ExpreS2ion Biotechnologies. ExpreS2ion Biotechnologies is a Biotech related company founded in 2010 with an estimated revenue of $4.2M, and 27 employees. It has 10 competitors โ€ฆSee details»

Farshad Guirakhoo, PhD - ExpreS2ion Biotechnologies | LinkedIn

Mar 24, 2022 Dr. Farshad Guirakhoo serves as Chief Scientific Officer at Expres2ion Biotechnologies HQโ€ฆ · Experience: ExpreS2ion Biotechnologies · Location: Geneva โ€ฆSee details»

Proteins for life - ExpreS2ion Biotechnologies

Organization to extend the ompanyโ€™s runway. Unfortunately, this meant parting ways with talented colleagues who have ... EXPRES2ION BIOTECHNOLOGIES APS ExpreS2ion โ€ฆSee details»

Annual report 2023 Innovative vaccines for a healthier world

Achievements and progress of ExpreS2ion Biotechnologies, an innovator in developing novel vaccines for a healthier world. A word from our CEO Dear shareholders, The year 2023 was โ€ฆSee details»

Disease focus - ExpreS2ion Biotechnologies

New research led by the World Health Organization has found that vaccines have saved an estimated 154 million lives in the past 50 years from 14 different diseases. ... ExpreS2ion โ€ฆSee details»

ExpreS2ion Biotechnologies Aps - DevelopmentAid

ExpreS2ion Biotechnologies Aps โ€” Consulting Organization from Denmark, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Research, Science & Innovation sectors. โ€ฆSee details»

Compass Pathways Announces Dosing Complete for All ... - BioSpace

1 day ago Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated โ€ฆSee details»

linkstock.net © 2022. All rights reserved